EUVIMEDEUVIMED entdecken
Crossref

Semi-solid extrusion 3D printing of quercetin-loaded polyethylene oxide–poloxamer gel formulations: A proof-of-concept study

Kristiine Roostar, Oleh Koshovyi, Andres Meos, Ivo Laidmäe, Ain Raal, Urve Paaver, Jyrki Heinämäki

Journal of Pharmacy & Pharmacognosy Research · 01.07.2026 · 14 (4) · 2836

DOI: 10.56499/jppres_14.4.2836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy & Pharmacognosy Research, online erschienen am 01.07.2026. Verfasst von Kristiine Roostar und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Quercetin oral delivery is limited by low aqueous solubility, chemical instability, and poor bioavailability. Semi-solid extrusion (SSE) three-dimensional (3D) printing may provide a flexible approach for preparing individualized oral dosage forms for quercetin.

Aims

To develop and evaluate the feasibility of novel quercetin-loaded aqueous polyethylene oxide (PEO)-poloxamer gel inks for SSE 3D printing, and to investigate the physicochemical characteristics and in vitro performance of the resulting 3D-printed systems evaluated as candidates for oral formulation development.

Methods

Six aqueous-ethanolic gel formulations containing quercetin dihydrate, PEO, and either Tween 80, Eumulgin® SMO 20, Pluronic® F-68, Pluronic® F-108, or Pluronic® F-87 were prepared. Gel viscosity, microscopic appearance, Fourier transform infrared (FTIR) spectral homogeneity, printability, scaffold mass, surface area, quercetin content, and in vitro dissolution were evaluated. Quercetin was quantified by high-performance liquid chromatography (HPLC) and ultraviolet (UV) spectrophotometry.

Results

All formulations were printable, although quercetin crystals were detected microscopically in all gels. The addition of Tween 80 or poloxamers reduced viscosity and improved macroscopic homogeneity compared with the PEO-only formulation. Printed scaffolds showed uniform appearance and acceptable mass variation. Quercetin content in dried scaffolds was generally close to theoretical values. Poloxamer-containing formulations accelerated quercetin release. The Pluronic® F-68 formulation released approximately 95% of quercetin within 60 min, whereas the PEO-only formulation released approximately 51%.

Conclusions

This proof-of-concept study demonstrated that PEO-based gels containing Tween 80 or Pluronic® F-68 may represent suitable candidates for further development of SSE 3D printing of quercetin oral dosage forms. Further analytical validation, biorelevant dissolution, stability, and bioavailability studies are required.

Zitieren

APA

Roostar, K., Koshovyi, O., Meos, A., Laidmäe, I., Raal, A., Paaver, U., & Heinämäki, J. (2026). Semi-solid extrusion 3D printing of quercetin-loaded polyethylene oxide–poloxamer gel formulations: A proof-of-concept study. Journal of Pharmacy & Pharmacognosy Research, 14(4), 2836. https://doi.org/10.56499/jppres_14.4.2836

Vancouver

Roostar K, Koshovyi O, Meos A, Laidmäe I, Raal A, Paaver U, et al. Semi-solid extrusion 3D printing of quercetin-loaded polyethylene oxide–poloxamer gel formulations: A proof-of-concept study. Journal of Pharmacy & Pharmacognosy Research. 2026;14(4):2836. doi:10.56499/jppres_14.4.2836

BibTeX
@article{Roostar2026,
  author = {Roostar, Kristiine and Koshovyi, Oleh and Meos, Andres and Laidmäe, Ivo and Raal, Ain and Paaver, Urve and Heinämäki, Jyrki},
  title = {Semi-solid extrusion 3D printing of quercetin-loaded polyethylene oxide–poloxamer gel formulations: A proof-of-concept study},
  journal = {Journal of Pharmacy & Pharmacognosy Research},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {2836},
  doi = {10.56499/jppres_14.4.2836}
}
Kostenlos starten →